Adaptive Biotechnologies (“we” or “our”) is a commercial-stage biotechnology company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment ...

Stanley M. Gartler, a molecular biologist and geneticist who helped provide the first convincing evidence that cancerous ...

He provided the first convincing evidence that cancerous tumors develop from a single mutated cell and later helped expose ...

“If there’s one thing I can say about cancer treatment, it’s that no one should have to go through it alone,” says one survivor of Hodgkin lymphoma.

Pfizer announced it will lay off 100 workers at the former Seagen campus in Bothell. The pharmaceutical company cited its advancements in productivity and efficiency, achieved through automation, as ...

Pfizer laid off 100 employees in Bothell, Wash., according to a filing with the state Employment Security Department posted on Monday. The pharmaceutical giant established a significant presence in ...

The field of human genetics and genomics research has seen spectacular progress and advances in human health and well-being that are nothing short of remarkable. In just a few years, we have been able ...

Seagen, formally called Seattle Genetics, had plans to build a 270,000 square foot facility on 20 acres at 215 Shuksan Way. The facility investment was going to be around $500 million and was expected ...

WASHINGTON – An advisory committee voted unanimously for accelerated approval for two lymphoma indications for Seattle Genetics Inc.'s Adcetris, but the company has its work cut out for it if it hopes ...

Pfizer’s plan to acquire Seagen for $43 billion has cleared the necessary regulatory hurdles, the pharma titan announced Tuesday. The deal will close on Thursday. Seagen is the largest biotech company ...

It has been about a month since the last earnings report for Seattle Genetics (SGEN). Shares have lost about 0.7% in that time frame, underperforming the S&P 500. Will the recent negative trend ...